Fibromyalgia (FM or FMS)

Assessing the Clinical Value of Cannabis-Based Treatments on Fibromyalgia Pain

Hendrickson, Blake, et al.

Journal of Psychological Inquiry. 2013, 18(2): 6-14 (Full).  

​

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials

Lynch, Mary E, et al.

British Journal of Clinical Pharmacology. 2011 Oct 11, 72(5): 735-744 (Full).

​

Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life

Fiz, Jimena, et al.

PlosOne, 2011 Apr 21, (online article).

​

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

Ware, Mark A, et al. 

CMAJ. 2010 Oct 5, 182(14) (online article).

​

The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial

Ware, Mark A, et al.

Anesthesia & Analgesia. 2010 Feb, 110(2): 604-610 (Full). 

​

Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey

Weber, Janet, et al.

Anesthesiology Research and Practice. 2009, (online article).

​

Cannabinoids and Pain

King, Steven A.

Rheumatology Network. 2008 Feb 1, (online article).

​

The Pharmacological and Clinical Effects of Medical Cannabis

Borgelt, Laura M, et al.

Pharmacotherapy. 2013 Feb 5, 33(2): 195-209 (abstract).

​

Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State

Aggarwal, SK, et al.

Journal of Opioid Management. 2009, 5(5): 257-286 (abstract). 

​

Future of Cannabis and Cannabinoids in Therapeutics

Russo, Ethan B.

Journal of Cannabis Therapeutics. 2008 Oct 15, 3(4): 163-174 (abstract).

​

Nabilone for the Treatment of Pain in Fibromyalgia

Skrabek, Ryan Quinlan, et al.

The Journal of Pain. 2008 Feb, 9(2): 164-173 (abstract).

​

Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex, a Cannabis-Based Medicine

Russo, Ethan B, et al.

Chemistry & Biodiversity. 2007 Aug 21, 4(8): 1729-1743 (abstract).

​

Delta-9 THC based monotherapy in fibromyalgia patients on experimentally induced pain, axon reflex flare, and pain relief

Schley, Marcus, et al.

Current Medical Research and Opinion. 2006, 22(7): 1269-1276 (abstract).

​

Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

Russo, EB.

Neuro Endocrinology Letters. 2004, 25(1-2): 31-39 (abstract).